.jpg)
What is Teva Pharmaceutical Industries Limited (Teva) stock price?
Teva Pharmaceutical Industries Limited's stock symbol is TEVA and currently trades under NYSE. It’s current price per share is approximately $ 8.97. What are your Teva Pharmaceutical Industries Limited (TEVA) stock predictions? 18 Wall Street analysts have issued ratings.
What price target do analysts set for Teva?
What price target have analysts set for TEVA? 10 brokerages have issued 1-year target prices for Teva Pharmaceutical Industries' stock. Their forecasts range from $8.00 to $14.00. On average, they anticipate Teva Pharmaceutical Industries' share price to reach $11.25 in the next twelve months.
Where can I buy shares of Teva?
Shares of TEVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Why did Teva’s shares jump Monday?
Teva Pharmaceutical Industries Ltd. shares jumped 9.7% in afternoon trade Monday, after the Israeli generics company said it has reached a settlement with a group of attorneys general from North Carolina, Pennsylvania, Tennessee and Texas, along with defendants, to resolve litigation relating to opioid cases.
See more
Is Teva Pharmaceutical a good stock to buy?
Right now, Teva is a perennially underperforming company, not an undervalued or misunderstood gem. There isn't any general expectation for rapid growth in Teva's revenue or earnings. The company also isn't exposed to any positive catalysts which could drive share price appreciation.
Is Teva undervalued?
Teva Pharmaceutical has a current Real Value of $16.61 per share. The regular price of the company is $7.06. At this time, the company appears to be undervalued.
Is Teva Pharmaceuticals public?
Until 2020, Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed by US-based Pfizer. Overall, Teva is the 18th largest pharmaceutical company in the world....Teva Pharmaceuticals.Teva Pharmaceuticals logoTypePublic companyNumber of employees40,039 (2019)Websitetevapharm.com teva.co.il11 more rows
Does Teva Pharmaceuticals pay a dividend?
TEVA does not currently pay a dividend.
What is the future of Teva Pharmaceuticals?
Teva Pharmaceutical Industries is bordering on breakeven, according to the 19 American Pharmaceuticals analysts. They anticipate the company to incur a final loss in 2020, before generating positive profits of US$1.5b in 2021. The company is therefore projected to breakeven around a year from now or less!
Is Teva going out of business?
Based on the latest financial disclosure, Teva Pharmaceutical Industries has a Probability Of Bankruptcy of 51%. This is 17.81% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry.
Is Teva an Israeli company?
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products.
What drugs does Teva sell?
Specialty Medicines ListACTIQ® (fentanyl citrate) oral transmucosal lozenge, C-II. ... ADIPEX-P® (phentermine hydrochloride USP) Capsules and Tablets, C-IV. ... AirDuo RespiClick® (fluticasone propionate and salmeterol) Inhalation Powder. ... AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder.More items...
When will Teva release its earnings?
When is Teva earnings call?
Teva Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Wednesday, July 28th 2021. View our earnings forecast for Teva Pharmaceutical Industries.
Results
- Teva Pharmaceutical Industries Ltd (NYSE:TEVA) posted its quarterly earnings results on Thursday, May, 2nd. The company reported $0.57 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.02. The business earned $4.30 billion during the quarter, compared to the consensus estimate of $4.38 billion. Teva Pharmaceutical Industries h…
Business
- Teva Pharmaceutical Industries is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Teva Pharmaceutical Industries. Teva Pharmaceutical Industries issued an update on its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share (EPS) guidance of $2.20-2.50 fo…
Risks
- 22 equities research analysts have issued 12-month target prices for Teva Pharmaceutical Industries' stock. Their predictions range from $12.00 to $30.00. On average, they anticipate Teva Pharmaceutical Industries' stock price to reach $20.3333 in the next year. This suggests a possible upside of 41.6% from the stock's current price. View Analyst P...
Ratings
- 22 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Teva Pharmaceutical Industries in the last year. There are currently 1 sell rating, 16 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of \"Hold.\" View Analyst Ratings for Teva Pharmaceutical Industries. Headlines about TEVA stock have trended s…
Ownership
- Teva Pharmaceutical Industries' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Abrams Capital Management L.P. (1.77%), Harel Insurance Investments & Financial Services Ltd. (0.52%), Beck Mack & Oliver LLC (0.41%), Swiss National Bank (0.35%), Sumitomo Mitsui Trust Holdings Inc. (0.35%) and Migdal Insurance & Fin…
Operations
- Teva Pharmaceutical Industries has a market capitalization of $14.60 billion and generates $18.85 billion in revenue each year. The company earns $-2,150,000,000.00 in net income (profit) each year or $2.80 on an earnings per share basis. Teva Pharmaceutical Industries employs 42,535 workers across the globe.
Transport
- Teva Pharmaceutical Industries' mailing address is 5 BAZEL ST P O B 3190, PETACH TIKVA L3, 4951033. The company can be reached via phone at 972-926-7267 or via email at [email protected].